167 related articles for article (PubMed ID: 9203536)
1. Characterization of the effect of dopamine D3 receptor stimulation on locomotion and striatal dopamine levels.
De Boer P; Enrico P; Wright J; Wise LD; Timmerman W; Moor E; Dijkstra D; Wikström HV; Westerink BH
Brain Res; 1997 May; 758(1-2):83-91. PubMed ID: 9203536
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
Pugsley TA; Davis MD; Akunne HC; MacKenzie RG; Shih YH; Damsma G; Wikstrom H; Whetzel SZ; Georgic LM; Cooke LW
J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
[TBL] [Abstract][Full Text] [Related]
4. Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.
Richtand NM; Welge JA; Levant B; Logue AD; Hayes S; Pritchard LM; Geracioti TD; Coolen LM; Berger SP
Neuropsychopharmacology; 2003 Aug; 28(8):1422-32. PubMed ID: 12700693
[TBL] [Abstract][Full Text] [Related]
5. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
Koshikawa N; Kitamura M; Kobayashi M; Cools AR
Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D3 agonists disrupt social behavior in rats.
Kagaya T; Yonaga M; Furuya Y; Hashimoto T; Kuroki J; Nishizawa Y
Brain Res; 1996 May; 721(1-2):229-32. PubMed ID: 8793104
[TBL] [Abstract][Full Text] [Related]
7. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
Koshikawa N; Miwa Y; Adachi K; Kobayashi M; Cools AR
Eur J Pharmacol; 1996 Jul; 308(3):227-34. PubMed ID: 8858292
[TBL] [Abstract][Full Text] [Related]
8. Intra-accumbens infusion of D(3) receptor agonists reduces spontaneous and dopamine-induced locomotion.
Ouagazzal AM; Creese I
Pharmacol Biochem Behav; 2000 Nov; 67(3):637-45. PubMed ID: 11164096
[TBL] [Abstract][Full Text] [Related]
9. Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect?
Boulay D; Depoortere R; Perrault G; Sanger DJ
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Jan; 24(1):39-49. PubMed ID: 10659982
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists.
Boulay D; Depoortere R; Perrault G; Borrelli E; Sanger DJ
Neuropharmacology; 1999 Sep; 38(9):1389-96. PubMed ID: 10471093
[TBL] [Abstract][Full Text] [Related]
11. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
[TBL] [Abstract][Full Text] [Related]
12. The D2/D3 agonist PD128907 (R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol) inhibits stimulated pyloric relaxation and spontaneous gastric emptying.
Kashyap P; Micci MA; Pasricha S; Pasricha PJ
Dig Dis Sci; 2009 Jan; 54(1):57-62. PubMed ID: 18600456
[TBL] [Abstract][Full Text] [Related]
13. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
[TBL] [Abstract][Full Text] [Related]
14. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo characterization of the agonist-dependent D3 dopamine receptor tolerance property.
Cote SR; Kuzhikandathil EV
Neuropharmacology; 2014 Apr; 79():359-67. PubMed ID: 24316466
[TBL] [Abstract][Full Text] [Related]
16. 7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment.
Pritchard LM; Logue AD; Hayes S; Welge JA; Xu M; Zhang J; Berger SP; Richtand NM
Neuropsychopharmacology; 2003 Jan; 28(1):100-7. PubMed ID: 12496945
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice.
Boulay D; Depoortere R; Rostene W; Perrault G; Sanger DJ
Neuropharmacology; 1999 Apr; 38(4):555-65. PubMed ID: 10221759
[TBL] [Abstract][Full Text] [Related]
18. Biphasic effects of D3-receptor agonists, 7-OH-DPAT and PD128907, on the D1-receptor agonist-induced hyperactivity in mice.
Mori T; Murase K; Tanaka J; Ichimaru Y
Jpn J Pharmacol; 1997 Mar; 73(3):251-4. PubMed ID: 9127821
[TBL] [Abstract][Full Text] [Related]
19. The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats.
Millan MJ; Seguin L; Gobert A; Cussac D; Brocco M
Psychopharmacology (Berl); 2004 Jul; 174(3):341-57. PubMed ID: 14985929
[TBL] [Abstract][Full Text] [Related]
20. Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptors.
Millan MJ; Girardon S; Monneyron S; Dekeyne A
Neuropharmacology; 2000 Feb; 39(4):586-98. PubMed ID: 10728880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
